Ahmadi S, Rahimian E, Rahimi S, Zarandi B, Bahraini M, Soleymani M
Biomark Res. 2024; 12(1):137.
PMID: 39538363
PMC: 11565275.
DOI: 10.1186/s40364-024-00676-9.
Zhao Y, Laird A, Roberts K, Yafawi R, Kantarjian H, DeAngelo D
Blood Adv. 2024; 8(12):3226-3236.
PMID: 38607410
PMC: 11225676.
DOI: 10.1182/bloodadvances.2023012430.
Arai H, Matsui H, Chi S, Utsu Y, Masuda S, Aotsuka N
Int J Mol Sci. 2024; 25(1).
PMID: 38203823
PMC: 10779750.
DOI: 10.3390/ijms25010652.
Johansson K, Zimmerman M, Dmytrenko I, Gao F, Link D
Leukemia. 2023; 37(12):2356-2366.
PMID: 37838759
PMC: 10681904.
DOI: 10.1038/s41375-023-02057-x.
Gasparoli L, Virely C, Tsakaneli A, Che N, Edwards D, Bartram J
Haematologica. 2023; 109(4):1069-1081.
PMID: 37794795
PMC: 10985450.
DOI: 10.3324/haematol.2023.283613.
Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia.
Panuciak K, Nowicka E, Mastalerczyk A, Zawitkowska J, Niedzwiecki M, Lejman M
Int J Mol Sci. 2023; 24(10).
PMID: 37240110
PMC: 10218510.
DOI: 10.3390/ijms24108764.
Treatment for a B-cell acute lymphoblastic leukemia patient carrying a rare c.C275T mutation: A case report.
Wang R, Wang W, Liu X, Wang H, Zhang B, Li S
Front Oncol. 2023; 12:1018250.
PMID: 36798689
PMC: 9928200.
DOI: 10.3389/fonc.2022.1018250.
Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.
Chitadze G, Stengel A, John-Klaua C, Bruckmuller J, Trautmann H, Kotrova M
Blood. 2022; 141(13):1640-1644.
PMID: 36450137
PMC: 10651768.
DOI: 10.1182/blood.2022017249.
Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia.
Douglas S, Lahtinen A, Koski J, Leimi L, Keranen M, Koskenvuo M
Sci Rep. 2022; 12(1):10670.
PMID: 35739278
PMC: 9225984.
DOI: 10.1038/s41598-022-14364-x.
Association of TP53 gene polymorphisms with the risk of acute lymphoblastic leukemia in Moroccan children.
Skhoun H, Khattab M, Belkhayat A, Chebihi Z, Bakri Y, Dakka N
Mol Biol Rep. 2022; 49(9):8291-8300.
PMID: 35705773
DOI: 10.1007/s11033-022-07643-3.
Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findings.
Sukhanova M, Obeidin F, Streich L, Alexiev B
Genes Chromosomes Cancer. 2022; 61(11):653-661.
PMID: 35655404
PMC: 9545443.
DOI: 10.1002/gcc.23072.
Near-Haploidy and Low-Hypodiploidy in B-Cell Acute Lymphoblastic Leukemia: When Less Is Too Much.
Molina O, Bataller A, Thampi N, Ribera J, Granada I, Velasco P
Cancers (Basel). 2022; 14(1).
PMID: 35008193
PMC: 8750410.
DOI: 10.3390/cancers14010032.
A prognostic approach on a case of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia with monosomy-7.
Skhoun H, Khattab M, Belkhayat A, Chebihi Z, Dakka N, El Baghdadi J
Clin Case Rep. 2021; 9(12):e05207.
PMID: 34963805
PMC: 8710846.
DOI: 10.1002/ccr3.5207.
Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia.
Iacobucci I, Kimura S, Mullighan C
J Clin Med. 2021; 10(17).
PMID: 34501239
PMC: 8432032.
DOI: 10.3390/jcm10173792.
[Clinical and prognostic values of TP53 mutation in patients with B-lineage acute lymphoblastic leukemia].
Du Y, Lyu K, Xu M, Yao W, Kang H, Han Y
Zhonghua Xue Ye Xue Za Zhi. 2021; 42(5):396-401.
PMID: 34218582
PMC: 8292997.
DOI: 10.3760/cma.j.issn.0253-2727.2021.05.008.
Hypodiploidy in a pediatric patient of T-cell acute lymphoblastic leukemia: a case report.
Stefaniak M, Reka G, Zawitkowska J, Lejman M
BMC Med Genomics. 2021; 14(1):178.
PMID: 34217275
PMC: 8254919.
DOI: 10.1186/s12920-021-01023-9.
Single nucleotide polymorphism array-based signature of low hypodiploidy in acute lymphoblastic leukemia.
Creasey T, Enshaei A, Nebral K, Schwab C, Watts K, Cuthbert G
Genes Chromosomes Cancer. 2021; 60(9):604-615.
PMID: 33938069
PMC: 8600946.
DOI: 10.1002/gcc.22956.
[The effect of TP53 mutations on the clinical outcomes of Ph-negative B-acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation].
Cao X, Zhang Y, Liu D, Zhang J, Wei Z, Xiong M
Zhonghua Xue Ye Xue Za Zhi. 2020; 41(11):908-914.
PMID: 33333693
PMC: 7767807.
DOI: 10.3760/cma.j.issn.0253-2727.2020.11.005.
Molecular markers in ALL: Clinical implications.
Kimura S, Mullighan C
Best Pract Res Clin Haematol. 2020; 33(3):101193.
PMID: 33038982
PMC: 7548398.
DOI: 10.1016/j.beha.2020.101193.
Therapeutic targeting of mutated p53 in acute lymphoblastic leukemia.
van Leeuwen F
Haematologica. 2020; 105(1):10-11.
PMID: 31894096
PMC: 6939537.
DOI: 10.3324/haematol.2019.234872.